Phase I study of selinexor in combination with dexamethasone, ifosfamide, carboplatin, etoposide chemotherapy in patients with relapsed or refractory peripheral T-cell or natural-killer/T-cell lymphoma
一项针对复发或难治性外周T细胞或自然杀伤/T细胞淋巴瘤患者的selinexor联合地塞米松、异环磷酰胺、卡铂、依托泊苷化疗的I期研究
期刊:Haematologica
影响因子:7.9
doi:10.3324/haematol.2020.251454
Tang, Tiffany; Martin, Peter; Somasundaram, Nagavalli; Lim, Cindy; Tao, Miriam; Poon, Eileen; Yunon, Maica Jd; Toh, Shu Q; Yan, Sean X; Farid, Mohamad; Chan, Jason Y; Lim, Soon T
